H2O2 mediated FLIP and XIAP down-regulation involves increased ITCH expression and ERK-Akt crosstalk in imatinib resistant Chronic Myeloid Leukemia cell line K562-Reference-Cited by-同舟云学术

H2O2 mediated FLIP and XIAP down-regulation involves increased ITCH expression and ERK-Akt crosstalk in imatinib resistant Chronic Myeloid Leukemia cell line K562

Published:2021-04 Issue: Volume:166 Page:265-276
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Paul Tamalika,Roy Rajdeep,Sarkar Rupak Dey,Sinha Samraj,Biswas Nabendu

Funder

Science and Engineering Research Board

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference48 articles.

1. Cellular stress responses: cell survival and cell death;Fulda;Int. J. Cell Biol.,2010

2. Senescence, apoptosis or autophagy? When a damaged cell must decide its path - a mini-review;Vicencio;Gerontology,2008

3. Cell death in the host response to infection;Labbé;Cell Death Differ.,2008

4. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, bcl-2 expression, and brain pathology;Su;J. Neuropathol. Exp. Neurol.,1997

5. REST and stress resistance in ageing and Alzheimer's disease;Lu;Nature,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer;Cancer Cell International;2024-07-09

2. Hesperidin/Salinomycin Combination; a Natural Product for Deactivation of the PI3K/Akt Signaling Pathway and Anti-Apoptotic Factors in KG1a Cells;Journal of Fluorescence;2024-06-25

3. H₂O₂mediated MAPK-mTOR crosstalk determines the XIAP and FLIP degradation pathways and development of resistance to Imatinib;2024-04-30

4. IL6 mediated cFLIP downregulation increases the migratory and invasive potential of triple negative breast cancer cell;2024-01-15

5. Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia;Genes & Diseases;2023-10